These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Identity of the "pink spot". Bell CE; Somerville AR Nature; 1966 Sep; 211(5056):1405-6. PubMed ID: 5969836 [No Abstract] [Full Text] [Related]
7. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"]. Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A Encephale; 1969; 58(4):360-76. PubMed ID: 5378191 [No Abstract] [Full Text] [Related]
8. 'Pink spot' in the urine of schizophrenics. Bourdillon RE; Clarke CA; Ridges AP; Sheppard PM; Harper P; Leslie SA Nature; 1965 Oct; 208(5009):453-5. PubMed ID: 5867585 [No Abstract] [Full Text] [Related]
9. Pink spot in schizophrenia. Br Med J; 1966 Jan; 1(5480):119. PubMed ID: 5901567 [No Abstract] [Full Text] [Related]
10. [Biochemical studies in schizophrenia. On the "pink spot" phenomenon]. Vogel WH Munch Med Wochenschr; 1967 Aug; 109(31):1633-41. PubMed ID: 5631559 [No Abstract] [Full Text] [Related]
11. "Pink spot" and its components in normal and schizophrenic urine. Siegel M; Tefft H J Nerv Ment Dis; 1971 Jun; 152(6):412-26. PubMed ID: 5562594 [No Abstract] [Full Text] [Related]
12. The identity of the so-called pink spot in schizophrenia and Parkinson's disease. Heslinga FJ; van Tilburg W; Stam FC Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324 [No Abstract] [Full Text] [Related]
13. Mauve spot and schizophrenia. Ellman GL; Jones RT; Rychert RC Am J Psychiatry; 1968 Dec; 125(6):849-51. PubMed ID: 5698458 [No Abstract] [Full Text] [Related]
14. [Molecular organicity of abnormal behaviors and mental disorders]. Laborit H Agressologie; 1972; 13(2):83-91. PubMed ID: 4342791 [No Abstract] [Full Text] [Related]
15. A pink spot in thyrotoxicosis. Widelitz M; Feldman W Biol Psychiatry; 1971; 3(2):181-4. PubMed ID: 5089913 [No Abstract] [Full Text] [Related]
16. A new concept and further support for the importance and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in urine of schizophrenic patients. Kalbhen DA; Braun G Pharmacology; 1973; 9(1):52-6. PubMed ID: 4708978 [No Abstract] [Full Text] [Related]
17. Aspects of tyrosine metabolism in schizophrenia. Williams CH Psychol Med; 1971 Aug; 1(4):286-91. PubMed ID: 5149869 [No Abstract] [Full Text] [Related]
18. [Determination and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in the urine of acute schizophrenics (author's transl)]. Braun G; Kalbhen DA; Müller J; Vahar-Matiar H Arch Psychiatr Nervenkr (1970); 1974 Mar; 218(3):195-210. PubMed ID: 4838948 [No Abstract] [Full Text] [Related]